Moreover, research has shown that levels of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), are significantly elevated in T2DM patients compared to healthy individuals. This evidence concerns the gene TNF and type 2 diabetes mellitus.